Henry Rosler, MD
Physical Medicine & Rehabilitation · Greenfield, WINPI 1679685945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $198 and has fallen 69.6% since, to $60 in 2025.
Across 33 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fidia Pharma USA Inc.$102
- Pfizer$67
- Lilly USA, LLC$59
- AbbVie$58
- Pacira Therapeutics, Inc.$47
- Biohaven Pharmaceuticals, Inc.$42
- plus $278 from 12 others
What the payments were for
- Food & beverage$653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fidia Pharma USA Inc. | 6 | $102 |
| Pfizer | 4 | $67 |
| Lilly USA, LLC | 3 | $59 |
| AbbVie | 3 | $58 |
| Pacira Therapeutics, Inc. | 2 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| Globus Medical | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Vertex | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Nevro Corp. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Abbott | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Amgen | 1 | $21 |
| Lundbeck LLC | 1 | $16 |
| GRT US Holding, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
How this compares
$653 in reported general payments places this provider in the 80th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.
See all physical medicine & rehabilitation providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 60 | $1,014 |
| Tramadol Hcl | 88 | $929 |
| Pregabalin | 34 | $603 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $507 |
| Tizanidine Hcl | 16 | $126 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Greenfield
- Henry AlbaGreenfield$1K
- Nicholas KetchumMilwaukee$573K
- Christopher CronsellMilwaukee$353K
- Karin GoodfriendMilwaukee$191K
- John McGuireMilwaukee$75K
- Erin McGonigleMilwaukee$66K
- Noelle LiskaMilwaukee$13K
- Trinh TruongMilwaukee$11K
- Bindiya ShahMilwaukee$10K
- Michelle FaullMonroe$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.